| Literature DB >> 32260262 |
Sze Wa Chan1, Brian Tomlinson2.
Abstract
Metabolic syndrome is a cluster of interrelated conditions that is associated with an increased risk of cardiovascular disease (CVD) and type 2 diabetes mellitus (T2DM). Oxidative stress may impair normal physiological functions, leading to various illnesses. T2DM is considered to be associated with increased oxidative stress, inflammation, and dyslipidemia, which may play a significant role in the development of cardiovascular complications, cancer and vision loss through cataracts and retinopathy. While conventional therapies are a cornerstone for the management of the major risk factors of metabolic syndrome, increasing antioxidant defense by increasing intake of antioxidant-rich foods may improve long term prospects in CVD, obesity and T2DM. Bilberry (Vaccinium myrtillus L.) is one of the richest natural sources of anthocyanins which give berries their red/purple/blue coloration. Anthocyanins are powerful antioxidants and are reported to play an important role in the prevention of metabolic disease and CVD as well as cancer and other conditions. This review focuses on the potential effects of bilberry supplementation on metabolic and cardiovascular risk factors. Although there is evidence to support the use of bilberry supplementation as part of a healthy diet, the potential benefits from the use of bilberry supplementation in patients with T2DM or CVD needs to be clarified in large clinical trials.Entities:
Keywords: anti-inflammatory; antioxidant; bilberry; cardiovascular disease; hypoglycemic effect; type 2 diabetes
Mesh:
Substances:
Year: 2020 PMID: 32260262 PMCID: PMC7180827 DOI: 10.3390/molecules25071653
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Structures of the main anthocyanin-3-O-glucosides found in bilberry and respective wavelength at the maximum absorption in the visible region (λmax). Note that anthocyanins have characteristic colors, but the color of anthocyanins can change with the pH of the solution [11,20].
Intervention studies of bilberry. LDL: low-density lipoprotein; hsCRP: high-sensitivity C-reactive protein; IL: interleukin; LPS: lipopolysaccharide; NF-κB: nuclear factor-κB; sVCAM-1: soluble vascular cell adhesion molecule-1; HDL: high-density lipoprotein; CETP: cholesteryl ester transfer protein; CVD: cardiovascular disease; T2DM: type 2 diabetes mellitus; CADP-CT: closing time in platelet function analyzer with collagen and ADP; FMD: flow-mediated dilation; cGMP: cyclic guanosine monophosphate.
| Authors | Type of Study | Subjects | Interventions | Findings |
|---|---|---|---|---|
| Antioxidant effect | ||||
| Marniemi et al. [ | Randomized controlled trial | 60 healthy volunteers | 100 g deep-frozen berries (bilberries, lingonberries, or blackcurrants) daily for 8 weeks; 240 g berries in postprandial study; or 500 g calcium gluconate | Increased serum ascorbate, slight decrease in LDL oxidation, slight increase in serum antioxidant capacity in berry group; decreased LDL oxidation in postprandial study |
| Duthie et al. [ | Randomized controlled trial | 20 healthy volunteers | 750 mL/day of cranberry juice (Ocean Spray Cranberry Select) or placebo drink (natural mineral water with strawberry flavor + sucrose (9 g/100mL)) for 2 weeks | No effect on blood or cellular antioxidant status, lipid status, or oxidative DNA damage between groups |
| Karlsen et al. [ | Randomized controlled trial | 62 volunteers with increased risk of CVD | 330 mL/day bilberry juice (Corona Safteri, Rotvoll, Norway) or water for 4 weeks | No effect on antioxidant status or oxidative stress |
| Arevstrom et al. [ | Randomized controlled trial | 50 patients who were within 24 h of percutaneous coronary intervention | Bilberry powder (40 g/d, equivalent to 480 g fresh bilberries) or no supplementation over 8 weeks | Reduced total and LDL cholesterol compared to baseline; no difference in total and LDL cholesterol between groups |
| Anti-inflammatory effect | ||||
| Kolehmainen et al. [ | Randomized controlled trial | 27 volunteers with features of metabolic syndrome | 400 g/day fresh bilberries or habitual diet for 8 weeks | Reduced hsCRP, IL-6, IL-12, and LPS concentrations |
| Karlsen et al. [ | Randomized controlled trial | 62 volunteers with increased risk of CVD | 330 mL/day bilberry juice (Corona Safteri, Rotvoll, Norway) or water for 4 weeks | Modulate NF-κB relatedinflammatory markers |
| Karlsen et al. [ | Randomized controlled trial | 120 healthy volunteers | 300 mg/day Medox (with purified anthocyanins isolated from bilberries and blackcurrant), or placebo (maltodextrin) capsules for 3 weeks | Decreased NF-kB related pro-inflammatory chemokines, cytokines, and mediators of inflammatory responses |
| Zhu et al. [ | Randomized placebo controlled, double-blinded trial | 150 hypercholesterolemia subjects | Anthocyanins (320 mg/d) purified from bilberry and blackcurrant, or placebo for 24 weeks | Decreased hsCRP, sVCAM-1, IL-1b and LDL cholesterol and increased HDL cholesterol |
| Freese et al. [ | Randomized controlled trial | 96 healthy volunteers | Experimental diets either poor or rich in vegetables, berries and apple, and either richin linoleic acid or oleic acid for 6 weeks | No effect on platelet activation or inflammation markers |
| Hypoglycemic effect | ||||
| Hoggard et al. [ | Randomized placebo controlled, double-blinded cross-over study | 8 volunteers with T2DM controlled by diet and lifestyle | 0.47 g bilberry extract (36% (w/w) anthocyanins) capsule or placebo | Decreased postprandial glycemia and insulin level |
| Qin et al. [ | Randomized placebo controlled, double-blinded trial | 120 overweight dyslipidemic subjects | 160 mg anthocyanins twice daily or placebo for 12 weeks | No difference in glucose levels between groups |
| Effects on dyslipidemia | ||||
| Qin et al. [ | Randomized placebo controlled, double-blinded trial | 120 overweight dyslipidemic subjects | 160 mg anthocyanins twice daily or placebo for 12 weeks | Decreased LDL cholesterol and increased HDL cholesterol and inhibited CETP |
| Erlund et al. [ | Randomized, placebo controlled, single-blind, trial | 71 volunteers with at least one CV risk factor | 100 g whole bilberries and 50 g lingonberries one every other day, and blackcurrant or strawberry purée and cold-pressed chokeberry and raspberry juice on alternative day, or placebo (sugar water, sweet semolina porridge, sweet rice porridge and marmalade sweets) for 8 weeks | Reduced blood pressure, increased HDL cholesterol and prolonged PFA-100 CTs (CADP-CT) |
| Zhu et al. [ | Randomized controlled, double-blinded trial | 150 hypercholesterolemic subjects | 320 mg/d anthocyanins purified from bilberry and blackcurrant, or placebo for 12 weeks | Increased FMD, cGMP, and HDL cholesterol, and decreased serum sVCAM-1 and LDL cholesterol |
| Zhu et al. [ | Randomized placebo-controlled, double-blind, parallel study | 122 hypercholesterolemic subjects | 320 mg/d anthocyanins purified from bilberry and blackcurrant, or placebo for 24 weeks | Increased HDL cholesterol and decreased LDL cholesterol |
| Anthocyanin | R1 | R2 | λmax (nm) * | |
|---|---|---|---|---|
| R3=H | R3=gluc | |||
| Delphinidin (15.17%) | OH | OH | 546 | 541 |
| Cyanidin (8.36%) | OH | H | 535 | 530 |
| Petunidin (6.64%) | OH | OCH3 | 543 | 540 |
| Malvidin (5.43%) | OCH3 | OCH3 | 542 | 538 |
| Peonidin (1.87%) | OCH3 | H | 532 | 528 |
| * In methanol with 0.01% HCl. | ||||